Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

Cited by (870)

Items 201–300 of 870

1. Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques
   Gregory Q. Del Prete, Rebecca S. Shoemaker, Kelli A. Oswald, Abigail Lara, Charles M. Trubey, Randy L. Fast, Douglas K. Schneider, Rebecca F. Kiser, Vicky J. Coalter, Adam Wiles et al. · 2014 · Antimicrobial Agents and Chemotherapy
2. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era
   Cristina Elena Brickman, Joel Michael Palefsky · 2015 · Current HIV/AIDS Reports
3. Finding a cure for HIV: will it ever be achievable?
   Sharon R. Lewin, Vanessa A. Evans, Julian H. Elliott, Bruno Spire, Nicolas Chomont · 2011 · Journal of the International AIDS Society
4. Multimorbidity and functional status assessment
   Giovanni Guaraldi, Ana Rita Silva, Chiara Stentarelli · 2014 · Current Opinion in HIV and AIDS
5. Bone health in HIV and hepatitis B or C infections
   Emmanuel Biver, Alexandra Calmy, René Rizzoli · 2016 · Therapeutic Advances in Musculoskeletal Disease
6. Building on the HIV platform
   Wafaa M. El-Sadr, Eric Goosby · 2018 · AIDS
7. Cardiovascular Complications of HIV in Endemic Countries
   Matthew J. Feinstein, Milana Bogorodskaya, Gerald S. Bloomfield, Rajesh Vedanthan, Mark Jacob Siedner, Gene F. Kwan, Chris Todd Longenecker · 2016 · Current Cardiology Reports
8. HIV Associated Risk Factors for Ischemic Stroke and Future Perspectives
   Saifudeen Ismael, Mohammad Moshahid Khan, Prashant Kumar, Sunitha Kodidela, Golnoush Mirzahosseini, Santosh Kumar, Tauheed Ishrat · 2020 · International Journal of Molecular Sciences
9. Evidence of inflammasome activation and formation of monocyte-derived ASC specks in HIV-1 positive patients
   Fareed Ahmad, Neha Mishra, Gerrit Ahrenstorf, Bernardo S. Franklin, Eicke Latz, Reinhold Ernst Schmidt, Lukas Bossaller · 2017 · AIDS
10. Metabolic Syndrome After HIV Acquisition in South African Women
    Magdalena E. Sobieszczyk, Lise Werner, Koleka Patience Mlisana, Nivashnee Naicker, Addi Feinstein, Clive M. Gray, Lindi Masson, Jo-Ann Shelley Passmore, Carolyn E. Williamson, Quarraisha Abdool Karim et al. · 2016 · JAIDS Journal of Acquired Immune Deficiency Syndromes
11. Practice Paper of the Academy of Nutrition and Dietetics: Nutrition Intervention and Human Immunodeficiency Virus Infection
    Amanda L. Willig, Lauri Y. Wright, Theresa A. Galvin · 2018 · Journal of the Academy of Nutrition and Dietetics
12. High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
    E. Aslangul, Soraya Fellahi, Lambert Assoumou, Jean‐Philippe Bastard, Jacqueline Capeau, Dominique G. Costagliola · 2011 · AIDS
13. Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy–Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review
    Josep Maria Llibre, Pedro Enrique Cahn, Janet Lo, Tristan Barber, Cristina Mussini, Berend J. van Welzen, Beatriz Hernandez, Cynthia Donovan, Michelle Kisare, Myooran Sithamparanathan et al. · 2022 · Open Forum Infectious Diseases
14. Circulating Levels of Tissue Factor Microparticle Procoagulant Activity Are Reduced With Antiretroviral Therapy and Are Associated With Persistent Inflammation and Coagulation Activation Among HIV-Positive Patients
    Jason V. Baker, Katherine Huppler Hullsiek, Robert L. Bradford, Rachel Prosser, Russell P. Tracy, Nigel S. Key · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
15. Persistently Elevated Serum Interleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial
    Bethan McDonald, Sikhulile M. Moyo, Lesego Gabaitiri, Simani Gaseitsiwe, Hermann Bussmann, John Robert Koethe, Rosemary Mubanga Musonda, Joseph M. Makhema, Vladimir Novitsky, Richard Marlink et al. · 2013 · AIDS Research and Human Retroviruses
16. A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz
    Laura Albini, Bruno Mario Cesana, Davide Motta, Emanuele Focà, Daria Gotti, Alessandra Calabresi, Ilaria Izzo, Rita Bellagamba, Rita Fezza, Pasquale Narciso et al. · 2011 · JAIDS Journal of Acquired Immune Deficiency Syndromes
17. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities
    Mathilde Ghislain, Jean‐Philippe Bastard, Laurence Meyer, Jacqueline Capeau, Soraya Fellahi, Laurence Gérard, Thierry May, Anne Simon, Corinne Vigouroux, Cécile Goujard et al. · 2015 · PLoS ONE
18. Does systemic inflammation and immune activation contribute to fracture risk in HIV?
    Tara McGinty, Paria Mirmonsef, Patrick W. G. Mallon, ALAN L. LANDAY · 2016 · Current Opinion in HIV and AIDS
19. Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study
    Ken M. Kunisaki, Davide De Francesco, Caroline Anne Sabin, Alan Winston, Patrick W. G. Mallon, Jane Anderson, Emmanouil Bagkeris, Marta Boffito, Nicki Doyle, Lewis John Haddow et al. · 2020 · Open Forum Infectious Diseases
20. HIV infection and atherosclerosis: evaluating the drivers of inflammation
    Archana Maniar, Collin L. Ellis, David M. Asmuth, Richard B. Pollard, John C. Rutledge · 2012 · European Journal of Preventive Cardiology
21. KSHV‐associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies
    Antonino Carbone, Paolo De Paoli, Annunziata Gloghini, Emanuela Vaccher · 2014 · International Journal of Cancer
22. Activation of NK cells is associated with HIV-1 disease progression
    Leticia Kuri-Cervantes, Gonzalo Salgado Montes de Oca, Santiago Ávila‐Ríos, Ramón Hernández‐Juan, Gustavo Reyes‐Terán · 2014 · Journal of Leukocyte Biology
23. A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy
    Susan Marie Graham, Nimerta Rajwans, Kenneth A. Tapia, Walter Godfrey Jaoko, Benson B. A. Estambale, Raymond Scott McClelland, Julie M. Overbaugh, Wayne Conrad Liles · 2013 · BMC Infectious Diseases
24. Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer
    John Charles A. Lacson, Revery P. Barnes, Hossein Bahrami · 2017 · Current Atherosclerosis Reports
25. Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation
    Thibaut Davy-Méndez, Sonia Napravnik, Oksana Igorevna Zakharova, JoAnn D. Kuruc, Cynthia L. Gay, Charles B. Hicks, Kara S. McGee, Joseph J. Eron · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
26. Altered Intestinal Permeability and Fungal Translocation in Ugandan Children With Human Immunodeficiency Virus
    Sahera Dirajlal‐Fargo, Vanessa El Kamari, Lukasz D. Weiner, Lingpeng Shan, Abdus Sattar, Manjusha Kulkarni, Nicholas Funderburg, Rashidah Nazzinda, Christine K. Karungi, Cissy M Kityo et al. · 2019 · Clinical Infectious Diseases
27. Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection
    Sophie Novelli, Camille Lécuroux, Cécile Goujard, Jacques Reynes, Agnès Villemant, L. Blum, Asma Essat, Véronique Avettand-Fènoël, Odile Launay, Jean‐Michel Molina et al. · 2020 · EBioMedicine
28. Mechanisms of Arrhythmia and Sudden Cardiac Death in Patients With HIV Infection
    Judith Brouillette, Samuel Cyr, Céline Fiset · 2018 · Canadian Journal of Cardiology
29. Inflammation and Complications of HIV Disease
    Michael P. Dubé, Fred R. Sattler · 2010 · The Journal of Infectious Diseases
30. Combination antiretroviral therapy and cancer risk
    Álvaro Humberto Borges · 2016 · Current Opinion in HIV and AIDS
31. Cardiovascular Risk Assessment in People Living With HIV: A Systematic Review and Meta-Analysis of Real-Life Data
    Marina Grand, Daniel Bia, Alejandro Díaz · 2019 · Current HIV Research
32. NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
    Caroline E. Mullis, Talia H. Swartz · 2020 · Frontiers in Cardiovascular Medicine
33. Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the W omen, I ntegrase and F at A ccumulation T rial
    Jordan E. Lake, GA McComsey, Todd Hulgan, CA Wanke, Alexandra Mangili, Sharon Lynn Walmsley, SA Stramotas, Russell P. Tracy, JS Currier · 2014 · HIV Medicine
34. Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients
    Agathe León, Lorna Leal, Berta Torres, Constanza Lucero, Alexy Inciarte, Mireia Arnedo, Montserrat Plana, Jordi Vilà, Josep Maria Gatell, Felipe García · 2015 · AIDS
35. One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study
    Christina K. Psomas, Mehwish Younas, Christelle Reynès, Renaud Cezar, Pierre Portalès, Édouard Tuaillon, Adeline Guigues, Corinne Merle, Nadine Atoui, Céline Fernandez et al. · 2016 · EBioMedicine
36. Variability in C-reactive protein is associated with cognitive impairment in women living with and without HIV: a longitudinal study
    Leah H. Rubin, Lorie Benning, Sheila Marie Keating, Philip J. Norris, Jane K. Burke-Miller, Antonia M. Savarese, Krithika N. Kumanan, Saria Awadalla, Gayle Springer, Kathyrn Anastos et al. · 2017 · Journal of NeuroVirology
37. Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial
    Jason V. Baker, Kathleen Huppler Hullsiek, Rachel A. Prosser, Daniel A. Duprez, Richard H. Grimm, Russell P. Tracy, Frank S. Rhame, Keith Henry, James D. Neaton · 2012 · PLoS ONE
38. Microbiome in human immunodeficiency virus infection
    Salas, January T., Chang, Theresa L. · 2014 · Clinics in Laboratory Medicine
39. The moral and fiscal implications of antiretroviral therapies for HIV in Africa
    Paul Collier, Olivier C. Sterck · 2018 · Oxford Economic Papers
40. HIV-Associated Cardiovascular Disease Pathogenesis: An Emerging Understanding Through Imaging and Immunology
    Jonathan A. Hudson, Rashida A. Ferrand, Samuel Nguku Gitau, Marianne Mureithi, Pasquale Maffia, Shirjel R. Alam, Anoop S.V. Shah · 2024 · Circulation Research
41. Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010
    James D. Neaton, Jacqueline Neuhaus, Sean Emery · 2010 · Current Opinion in HIV and AIDS
42. Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia
    Rudolph L. Gleason, Alexander W. Caulk, Daniel Seifu, Ivana Parker, Brani Vidaković, Helena Getenet, Getachew Assefa, Wondwossen Amogne · 2015 · PLoS ONE
43. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers
    Steven E. Lipshultz, Paige L. Williams, Bret Zeldow, James D. Wilkinson, KENNETH C. RICH, Russell B. Van Dyke, George R. Seage, Laurie B. Dooley, Jonathan R. Kaltman, George Kelly Siberry et al. · 2014 · AIDS
44. Cellular Senescence, Immunosenescence and HIV
    Tamàs Fülöp, Georges Herbein, Andrea Cossarizza, Jacek Maciej Witkowski, Eric H. Frost, Gilles Dupuis, Graham Pawelec, Anis Larbi · 2016 · Interdisciplinary topics in gerontology and geriatrics
45. A pilot study of brisk walking in sedentary combination antiretroviral treatment (cART)- treated patients: benefit on soluble and cell inflammatory markers
    Matteo Bonato, Laura Galli, Laura Passeri, Valeria Longo, Gaspare Pavei, Simona Bossolasco, C Bertocchi, Massimo Cernuschi, Giuseppe Balconi, Giampiero Merati et al. · 2017 · BMC Infectious Diseases
46. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?
    Peter D. Burbelo, Richard W. Price, Lars Hagberg, Hiroyu Hatano, Serena Spudich, Steven G. Deeks, Magnus Gisslén · 2017 · The Journal of Infectious Diseases
47. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study
    José Castillo‐Mancilla, Andrew N. Phillips, James D. Neaton, Jacqueline Neuhaus, Shweta Sharma, Jason V. Baker, Simon Collins, Sharon Mannheimer, Sarah Lilian Pett, Veronique Touzeau‐Römer et al. · 2019 · Journal of the International AIDS Society
48. Workshop report: “Towards a Cure: HIV Reservoirs and Strategies to Control Them”
    Richard J. Jefferys · 2010 · Journal of the International AIDS Society
49. The role of IL‐1β during human immunodeficiency virus type 1 infection
    Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani · 2022 · Reviews in Medical Virology
50. Cystatin C in HIV-infected patients: promising but not yet ready for prime time
    Amandine Gagneux‐Brunon, Christophe Mariat, Pierre Delanaye · 2012 · Nephrology Dialysis Transplantation
51. Distinct biomarker signatures in HIV acute infection associate with viral dynamics and reservoir size
    Jeffrey E. Teigler, Louise Leyre, Nicolas Chomont, Bonnie M. Slike, Ningbo Jian, Michael A. Eller, Nittaya Phanuphak, Eugene D. M. B. Kroon, Suteeraporn Pinyakorn, Leigh Anne Eller et al. · 2018 · JCI Insight
52. Cancer during HIV infection
    Marinho Marques da Silva Neto, Carlos Roberto Brites, Álvaro Humberto Borges · 2020 · Apmis
53. The association between alcohol use and cardiovascular disease among people living with HIV: a systematic review
    Natalie E. Kelso, David S. Sheps, Robert L. Cook · 2015 · The American Journal of Drug and Alcohol Abuse
54. Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy
    Claudio Ucciferri, Katia Falasca, Francesca Vignale, Marta Di Nicola, Eligio Pizzigallo, Jacopo Vecchiet · 2013 · Journal of Medical Virology
55. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy
    Moı̈se Desvarieux, Franck Boccara, Jean‐Luc Meynard, J.P. Bastard, Ziad Mallat, Bény Charbit, Ryan T. Demmer, Nabila Haddour, Soraya Fellahi, Alain Tedgui et al. · 2013 · AIDS
56. Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression
    Elizabeth Hamlyn, Sarah J. Fidler, Wolfgang Stöhr, David A. Cooper, Giuseppe Tambussi, Mauro Schechter, José María Miró, Myra O. McClure, Jonathan N Weber, Abdel G. Babiker et al. · 2013 · AIDS
57. High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid
    Thijs Booiman, Ferdinand W.N.M. Wit, Irma Maurer, Davide De Francesco, Caroline Anne Sabin, Agnes M. Harskamp, Maria Prins, Paolo Garagnani, Chiara Pirazzini, Claudio Franceschi et al. · 2017 · Open Forum Infectious Diseases
58. Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection
    Albert M. L. Anderson, Jeong Hoon Jang, Kirk A. Easley, Dietmar Fuchs, Magnus Gisslén, Henrik Zetterberg, Kaj Blennow, Ronald J. Ellis, Donald Franklin, Robert K. Heaton et al. · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
59. Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis
    Florent Guerville, Marine Vialemaringe, Céline Cognet, P. Duffau, Estibaliz Lazaro, Charles Cazanave, Fabrice Bonnet, Olivier Leleux, Rodrigue Rossignol, Benoı̂t Pinson et al. · 2023 · AIDS
60. Discrepant coagulation profile in HIV infection
    Anna Karen Haugaard, Tamara T. Lund, Carsten Birch, Frederikke Falkencrone Rönsholt, Marius Trøseid, Henrik Ullum, Jan Gerstoft, Per I. Johansson, Susanne Dam Nielsen, Sisse Rye Ostrowski · 2013 · AIDS
61. Inflammation and Fibrosis in HIV
    Priscilla Y. Hsue, Ahmed A Tawakol · 2016 · Circulation Cardiovascular Imaging
62. A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older
    Assawin Gongvatana, Erin E. Morgan, Jennifer E. Iudicello, Scott Lee Letendre, Igor Grant, Steven Paul Woods · 2014 · Journal of NeuroVirology
63. Decreases in Inflammatory and Coagulation Biomarkers Levels in HIV-Infected Patients Switching from Enfuvirtide to Raltegravir: ANRS 138 Substudy
    Érika Ferrari Rafael da Silva, Isabelle Charreau, Bernard Gourmel, Samia Mourah, Issa Kalidi, Brigitte Guillon, Nathalie De Castro, François Caron, Joséphine M. Braun, Jean‐Michel Molina et al. · 2013 · The Journal of Infectious Diseases
64. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir
    Jesper Falkesgaard Højen, Thomas A. Rasmussen, Karen Lise Dahl Andersen, Anni Assing Winckelmann, Rune R. Laursen, Jesper Damsgaard Gunst, Holger Jon Møller, Mayumi Fujita, Lars Jørgen Østergaard, Ole Schmeltz Søgaard et al. · 2015 · Molecular Medicine
65. Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV
    Lukasz D. Weiner, Mauricio Retuerto, Christopher L. Hager, Vanessa El Kamari, Lingpeng Shan, Abdus Sattar, Manjusha Kulkarni, Nicholas Funderburg, Mahmoud Afif Ghannoum, Sahera Dirajlal‐Fargo et al. · 2019 · AIDS Research and Human Retroviruses
66. Is low‐level HIV ‐1 viraemia associated with elevated levels of markers of immune activation, coagulation and cardiovascular disease?
    Olof Elvstam, Patrik Medstrand, Marianne Jansson, P-E Isberg, Magnus Gisslén, Per Björkman · 2019 · HIV Medicine
67. Inflammasomes as mediators of inflammation in HIV-1 infection
    Alice K. Min, Trinisia Fortune, Natalia Rodriguez, Esha Hedge, Talia H. Swartz · 2022 · Translational research
68. Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
    Ingjerd Wangensteen Manner, Morten Bækken, Olav Oektedalen, Ingrid Os · 2012 · Blood Pressure
69. Purinergic Receptors: Key Mediators of HIV-1 Infection and Inflammation
    Talia H. Swartz, George Dubyak, Benjamin K. Chen · 2015 · Frontiers in Immunology
70. Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment ( START ) trial
    Elsayed Z. Soliman, Shweta Sharma, Keikawus Arastéh, David Alain Wohl, Amit C. Achhra, Giuseppe Tambussi, Jemma L. O’Connor, James H. Stein, DA Duprez, JD Neaton et al. · 2015 · HIV Medicine
71. Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral Therapy
    Gregory Q. Del Prete, Kelli A. Oswald, Abigail Lara, Rebecca S. Shoemaker, Jeremy V Smedley, Rhonda MacAllister, Vicky J. Coalter, Adam Wiles, Rodney Wiles, Yuan Li et al. · 2015 · Antimicrobial Agents and Chemotherapy
72. Vascular Injury in Cancer Survivors
    Daniel A. Mulrooney, Anne Hudson Blaes, Daniel A. Duprez · 2012 · Journal of Cardiovascular Translational Research
73. Inflammation and pharmacokinetics: potential implications for HIV-infection
    Sharon M. Seifert, José Castillo‐Mancilla, Kristine Mace Erlandson, Peter L. Anderson · 2017 · Expert Opinion on Drug Metabolism & Toxicology
74. Immune status, and not HIV infection or exposure, drives the development of the oral microbiota
    Modupe Oluseun Coker, Emmanuel F. Mongodin, Samer S. El‐Kamary, Paul Akhigbe, Obinna Obuekwe, Austin I. Omoigberale, PATRICIA W. LANGENBERG, C.O. Enwonwu, Lauren E. Hittle, William A. Blattner et al. · 2020 · Scientific Reports
75. Human immunodeficiency virus and menopause
    Rupa Kanapathipillai, Martha Hickey, Michelle Giles · 2013 · Menopause The Journal of The North American Menopause Society
76. Effect of Darunavir on Lipid Profile in HIV-Infected Patients
    Edgar Turner Overton, Eduardo Arathoon, Ezio Baraldi, Frank L. Tomaka · 2012 · HIV Clinical Trials
77. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
    Sofie Jespersen, Karin Kaereby Pedersen, Birgitta Anesten, Henrik Zetterberg, Dietmar Fuchs, Magnus Gisslén, Lars Hagberg, Marius Trøseid, Susanne Dam Nielsen · 2016 · BMC Infectious Diseases
78. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
    SMU-MeCRU study group, Barbara Ensoli, Maphoshane Nchabeleng, Fabrizio Ensoli, Antonella Tripiciano, Stefania Bellino, Orietta Picconi, Cecilia Sgadari, Olimpia Longo, Lara Tavoschi et al. · 2016 · Retrovirology
79. Controlling the HIV/AIDS epidemic: current status and global challenges
    Thorsten Demberg, Marjorie Robert-Guroff · 2012 · Frontiers in Immunology
80. Regulation of Leishmania (L.) amazonensis Protein Expression by Host T Cell Dependent Responses: Differential Expression of Oligopeptidase B, Tryparedoxin Peroxidase and HSP70 Isoforms in Amastigotes Isolated from BALB/c and BALB/c Nude Mice
    Priscila Camillo Teixeira, Leonardo Garcia Velásquez, Ana Paula Lepique, Eloiza de Rezende, José Matheus Camargo Bonatto, Marcello A. Barcinski, Edécio Cunha‐Neto, Beatriz Simonsen Stolf · 2015 · PLoS neglected tropical diseases
81. Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
    Daniel B. Chastain, Harold M Henderson, Kayla R. Stover · 2015 · The Open AIDS Journal
82. Multimorbidity and Burden of Disease
    Todd Tarquin Brown, Giovanni Guaraldi · 2016 · Interdisciplinary topics in gerontology and geriatrics
83. Inflammation-related genes are associated with epigenetic aging in HIV
    the HNRP Group, Erin E. Sundermann, Mariam Hussain, David J. Moore, Steve Horvath, David T S Lin, Michael Steffen Kobor, Andrew J. Levine · 2019 · Journal of NeuroVirology
84. Effects of Exercise Training and Statin Use in People Living with Human Immunodeficiency Virus with Dyslipidemia
    Hugo Ribeiro Zanetti, Alexandre Gonçalves, Leandro Teixeira Paranhos Lopes, Edmar Lacerda Mendes, Leonardo Roever, Mário León Silva-Vergara, Fernando Freitas Neves, Elmiro Santos Resende · 2019 · Medicine & Science in Sports & Exercise
85. Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial
    Sarah Gimbel, Ana Olga Mocumbi, Kristjana Ásbjörnsdóttir, Joana Coutinho, Leonel Andela, Bonifacio Rodriguez Cebola, Heidi Craine, Jonny Crocker, Leecreesha Hicks, Sarah Holte et al. · 2020 · Implementation Science
86. The Effect of Antiretroviral Therapy on IL-6, IL-1β, TNF-α, IFN-γ Levels and their Relationship with HIV-RNA and CD4+ T Cells in HIV Patients
    Gülay Okay, Meliha Meriç Koç, Eray Metin Güler, Ayşegül Yabacı, Abdürrahim Koçyiğit, Yasemin Akkoyunlu · 2020 · Current HIV Research
87. Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease
    Álvaro Humberto Borges, Jeffrey Ian Weitz, Gary Collins, Jason V. Baker, Yves Lévy, Richard T. Davey, Andrew N. Phillips, James D. Neaton, Jens Dilling Lundgren, Steven G. Deeks · 2014 · AIDS
88. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression
    José Castillo‐Mancilla, Mary Morrow, Yap Boum, Helen Byakwaga, Jessica Elizabeth Haberer, Jeffrey N. Martin, David R. Bangsberg, Samantha MaWhinney, Nicholas Musinguzi, Yong Huang et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
89. Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV ‐infected individuals
    Gregory M. Lucas, Alessandro Cozzi‐Lepri, CM Wyatt, Frank A. Post, AM Bormann, Nancy F. Crum‐Cianflone, MJ Ross, INSIGHT SMART Study Group · 2013 · HIV Medicine
90. HIV infection, body composition changes and related metabolic complications: contributing factors and evolving management strategies
    Julian Falutz · 2011 · Current Opinion in Clinical Nutrition & Metabolic Care
91. Atypical Skeletal Muscle Profiles in Human Immunodeficiency Virus-Infected Asymptomatic Middle-Aged Adults
    Thanh Nga Tran, Viola Guardigni, Karol Mateusz Pencina, Anthony A. Amato, Michael Floyd, Brooke Brawley, Brian Mozeleski, Jennifer McKinnon, Erin A. Woodbury, Emily Heckel et al. · 2017 · Clinical Infectious Diseases
92. Personal carbon monoxide exposure, respiratory symptoms, and the potentially modifying roles of sex and HIV infection in rural Uganda: a cohort study
    Crystal M. North, Piers MacNaughton, Peggy S. Lai, Jose Vallarino, Samson Okello, Bernard Kakuhikire, Alexander C. Tsai, Márcia C. Castro, Mark Jacob Siedner, Joseph G. Allen et al. · 2019 · Environmental Health
93. Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV
    Amanda K. Jan, Julia V. Moore, Richard J. Wang, Maggie McGing, Carly K. Farr, Daniela D Moisi, Marlena Hartman-Filson, Robert Kerruish, Diane Jeon, Eula Lewis et al. · 2021 · AIDS
94. Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
    Ronald J. Ellis, Natalie Wilson, Scott N. Peterson · 2021 · Viruses
95. Dynamics of Regulatory T-Cells during Pregnancy: Effect of HIV Infection and Correlations with Other Immune Parameters
    Kelly M. Richardson, Adriana Weinberg · 2011 · PLoS ONE
96. Renal Dysfunction in the Setting of HIV/AIDS
    José María Miró, Frederic Cofán, Joan Carles Trullàs, Christian Manzardo, Carlos Cervera, Montserrat Tuset, Federico Oppenheimer, Merçè Brunet, Asunción Moreno, Josep Maria Campistol et al. · 2012 · Current HIV/AIDS Reports
97. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima–media thickness
    Joseph A. Delaney, Rebecca Scherzer, Mary Lou Biggs, Michael G Shliplak, Joseph F. Polak, Judith S. Currier, Richard A. Kronmal, CHRISTINE A. WANKE, Peter Bacchetti, Daniel H. O’Leary et al. · 2010 · AIDS
98. HIV Replication, Inflammation, and the Effect of Starting Antiretroviral Therapy on Plasma Asymmetric Dimethylarginine, a Novel Marker of Endothelial Dysfunction
    Jason V. Baker, Jacqueline Neuhaus, Daniel A. Duprez, Matthew S. Freiberg, José Ignacio Bernardino, Andrew D. Badley, Daniel E. Nixon, Jens Dilling Lundgren, Russell P. Tracy, James D. Neaton · 2012 · JAIDS Journal of Acquired Immune Deficiency Syndromes
99. HIV infection and arterial inflammation assessed by 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study
    Andreas Knudsen, Anne Mette Fisker Hag, Annika Loft, Eric von Benzon, Sune Høgild Keller, Holger Jon Møller, Anne‐Mette Lebech, Rasmus Sejersten Ripa, Andreas Kjær · 2014 · Journal of Nuclear Cardiology
100. Plasma plasminogen activator inhibitor-1 predicts myocardial infarction in HIV-1-infected individuals
     Andreas Knudsen, Terese Lea Katzenstein, Thomas Benfield, Niklas Rye Jørgensen, Gitte Kronborg, Jan Gerstoft, Niels Obel, Andreas Kjær, Anne‐Mette Lebech · 2014 · AIDS